The oncogenic BCR/ABL fusion gene found mainly chronic myeloid leukaemia (CML) is capable of inducing ROS levels in both human and murine cell lines [33, 34]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.